DUBLIN, May 13, 2019 /PRNewswire/ -- Mdcl today
announced it has joined the NVIDIA Inception program, which is
designed to nurture startups that are revolutionizing industries
with advancements in AI and data sciences.
Mdcl is an Irish start-up working to create a better everyday
life for people living with diabetes. Mdcl aims to do this through
StreamLine, a Diabetes Hospital Clinic Management
System. Consisting of three distinct components — Smart
Clinic, Connected Clinic & Data Intelligence — StreamLine
reduces clinic administration time, remotely monitors patients and
uses state-of-the-art algorithms and machine learning techniques to
assist with patient care.
The NVIDIA Inception program will benefit Mdcl by connecting its
data scientists to the latest breakthroughs in Artificial
Intelligence (AI) technology. Mdcl will use NVIDIA's
expertise in AI to aid in the development of software as a medical
device (SaMD) diabetes solutions that will have a positive impact
on the treatment and management of diabetes. Mdcl will use
NVIDIA GPUs for deep learning modelling techniques to build a
repository of disease estimators that can be used to accurately
predict in real time the likelihood of disease presence and
progression.
"At Mdcl, we believe that an early steer from an expert can save
weeks in development time. With NVIDIA's expertise in AI
relating to medical applications and the support of its Inception
program, we aim to accelerate our design process, bringing a better
product to market in a shorter time frame," said Seán McMahon,
co-founder & CEO of Mdcl.
NVIDIA's Inception program is a virtual accelerator program that
helps startups during critical stages of product development,
prototyping and deployment. Every Inception member gets a custom
set of ongoing benefits, from hardware grants and marketing support
to training with deep learning experts.
About Mdcl
Mdcl is a Medical Software Company
developing a Diabetes Hospital Clinic Management System called
StreamLine. Mdcl, founded by Seán McMahon, Declan Lee & Dr Tomás Ahern, is developing a
novel product that reduces clinic administration time, provides
usable & flexible data structures, increases patient
visibility, reduces waiting lists and optimizes patient care.
StreamLine is designed to meet the actual requirements of
Consultant Endocrinologists. It is designed so that
consultants can run their clinic the way they want to run it.
Mdcl's StreamLine platform, (which is currently being trialed by
an Irish Hospital), will revolutionize diabetes healthcare
delivery. The company is headquartered in Dublin, Ireland. To discover more, visit
www.mdcl.io.
Contact about this news:
Mdcl Ltd
Seán McMahon, Co-Founder & CEO.
e-mail: 214407@email4pr.com
phone: 0873122853
website: https://mdcl.io/
linkedIn: https://www.linkedin.com/in/seanjmcmahon/
View original content to download
multimedia:http://www.prnewswire.com/news-releases/mdcl-joins-nvidia-inception-program-300848171.html
SOURCE Mdcl Ltd